Buprenorphine And Naloxone Film, Soluble
Product Images NDC 31722-481

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 31722-481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg (12 3mg)

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg (12 3mg)
Packaging label for Buprenorphine and Naloxone Sublingual Film, with a strength of 12 mg buprenorphine per 3 mg naloxone. The dosage form is a sublingual film for buccal or sublingual administration. The label includes dosing instructions, storage conditions, manufacturer name Camber Pharmaceuticals, Inc., and a barcode. The label also displays product warnings and a yellow vertical band highlighting the strength.*
FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg (2 0.5mg)

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg (2 0.5mg)
Packaging label for Buprenorphine and Naloxone Sublingual Film, containing 2 mg buprenorphine and 0.5 mg naloxone per film. The label displays dosage instructions for sublingual and buccal administration, storage conditions, and warnings. The product is labeled by Camber Pharmaceuticals, Inc., with detailed usage and safety information on multiple sides of the carton.*
FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg (4 1mg)

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg (4 1mg)
Packaging label for Buprenorphine and Naloxone Sublingual Film, 4 mg/1 mg strength, by Camber Pharmaceuticals, Inc. The label includes usage instructions, storage information, and warnings for the soluble buccal and sublingual film dosage form. The label displays the product name, strength, and manufacturer with NDC and barcode information.*
FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg (8 2mg)

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg (8 2mg)
Packaging label for Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg per film, by Camber Pharmaceuticals, Inc. The label includes dosing instructions, storage conditions, administration methods (sublingual and buccal), and warnings about accidental ingestion. The film is supplied in a peelable blister pack format with usage information and the manufacturer’s details.*
FDA Label Image

Figure 2 (F 1)

Figure 2 (F 1)
Instructional images showing hands handling a single unit dose film pouch. The first panel shows a person tearing open the film pouch with their fingers, while the second panel shows the pouch being cut open with scissors, revealing the soluble film inside.*
FDA Label Image

Figure 3 (F 2)

Figure 3 (F 2)
An illustration showing an open mouth with a buccal or sublingual soluble film being placed inside, demonstrating the proper administration method of a buprenorphine and naloxone film.*
FDA Label Image

Figure 4 (F 3)

Figure 4 (F 3)
An instructional illustration showing the administration of buprenorphine and naloxone soluble film. The first panel depicts a person placing the film inside the mouth near the gum and cheek (buccal area), and the second panel shows the film positioned under the tongue (sublingual area) for dissolution.*
FDA Label Image

Figure 1 (T 7)

Figure 1 (T 7)
Illustration showing hands opening a sachet strip of Buprenorphine and Naloxone buccal/sublingual soluble film. The packaging appears white with black printed text and a barcode on the strip, demonstrating how to peel open the film packet for use.*
FDA Label Image

Buprenorphine (Stru)

Buprenorphine (Stru)
Chemical structure diagram of buprenorphine hydrochloride, showing the molecule's ring system, functional groups including hydroxyl, methyl, and cyclopropyl moieties, and the hydrochloride component.*
FDA Label Image

Naloxone (Structural Formula)

Naloxone (Structural Formula)
Chemical structure diagram of buprenorphine showing its molecular framework with hydroxyl, ketone, amine, and allyl groups, including the hydrochloride salt and dihydrate components as indicated by HCl and 2 H2O.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.